Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Citi Healthcare & Medtech Conference Transcript

Mar 01, 2023 / 08:30PM GMT
Release Date Price: $29.36 (-4.95%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Yes, we can look to get started here. Thank you guys for joining us. I'm Patrick Donnelly, the Tools and Diagnostics Analyst here at Citi. Happy to have the Guardant Health team here with us. We got Mike, the CFO; AmirAli, Co-CEO. So we talked some screening, some numbers, we can cover the whole thing here.

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Maybe Mike, probably starting with you, just in terms of the recent quarter -- it was last week. Just in terms of the numbers, the clinical piece came in well. You guys provided the initial guidance, the moving pieces there with clinical looking at 35-plus, but some other stuff, development services, things like that, moving around.

So maybe just start in terms of the trends you saw on the clinical side, and we can work our way into the guidance as well.

Michael Bell
Guardant Health, Inc. - CFO

Yes. I mean on the clinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot